News Releases Sona’s ‘THT’ Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
News Releases Sona to Engage with Medical Experts and Payors to Inform Regulatory and Commercialization Strategies for Its ‘THT’ Cancer Therapy
News Releases Positive Results of Second Assessment of Sona’s GNR Technology from U.S. Nanotechnology Characterization Laboratory